102 related articles for article (PubMed ID: 25670513)
1. Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer.
Leeder JS
Clin Pharmacol Ther; 2015 Feb; 97(2):119-21. PubMed ID: 25670513
[TBL] [Abstract][Full Text] [Related]
2. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
4. Individualized drug therapy.
Daly AK
Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing.
Hocum BT; White JR; Heck JW; Thirumaran RK; Moyer N; Newman R; Ashcraft K
Am J Health Syst Pharm; 2016 Jan; 73(2):61-7. PubMed ID: 26721535
[TBL] [Abstract][Full Text] [Related]
6. [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].
Johansen PW; Bergan S; Rootwelt H; Kvittingen EA; Rugstad HE
Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2781-3. PubMed ID: 12523145
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?
Stillemans G; Belkhir L; Hesselink DA; Haufroid V; Elens L
Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):601-611. PubMed ID: 29775551
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 genetic polymorphisms of Mexican indigenous populations.
Sosa-Macías M; Llerena A
Drug Metabol Drug Interact; 2013; 28(4):193-208. PubMed ID: 24145057
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenetic aspects of the activity of cytochromes P450 in the metabolism of antipsychotics].
Fursa OO; Kozlovskiĭ VL
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):111-22. PubMed ID: 25089317
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
Johansson I; Ingelman-Sundberg M
Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
14. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
[TBL] [Abstract][Full Text] [Related]
15. Use of plasmid-derived external quality control samples in pharmacogenetic testing.
van der Straaten T; Swen J; Baak-Pablo R; Guchelaar HJ
Pharmacogenomics; 2008 Sep; 9(9):1261-6. PubMed ID: 18781854
[TBL] [Abstract][Full Text] [Related]
16. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
17. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
Fan M; Bousman CA
Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic studies on the antipsychotic treatment. Current status and perspectives.
Gesteira A; Barros F; Martín A; Pérez V; Cortés A; Baiget M; Carracedo A
Actas Esp Psiquiatr; 2010; 38(5):301-16. PubMed ID: 21117005
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
Sim SC; Kacevska M; Ingelman-Sundberg M
Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
